StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$160.79−0.31 (-0.19%)

Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –

Novartis Promacta/Revolade Global Growth in Constant Currencies by Quarter

Promacta/Revolade Global Growth in Constant Currencies (% cc) (%)

QuarterlyAnnual

Novartis Promacta/Revolade Global Growth in Constant Currencies: -61.0% in Q3 2026, down 23.0 pts from a year earlier.

Latest, Q3 2026
-61.0%
Period ended Sep 30, 2026
Change on a year earlier
-23.0 pts
-38.0% in Q3 2025
History
27 quarters
Since Q4 2018
Sources
27
Documents cited below

Where the Q3 2026 figure comes from

“|| Promacta/Revolade 4 | 142 | 362 | – 61 | – 61”

Source: Novartis Form 6-K (0001114448-26-000014) ↗

Reported in Form 6-K & Form 20-F.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedPromacta/Revolade Global Growth in Constant Currencies (% cc) (%)Year on yearSource
Q3 2026Sep 30, 2026-61.0%-23.0 ptsNovartis Form 6-K (0001114448-26-000014) ↗
Q2 2026Jun 30, 2026-65.0%-56.0 ptsNovartis Form 6-K (0001114448-26-000012) ↗
Q1 2026Mar 31, 2026-68.0%-76.0 ptsNovartis Form 6-K (0001114448-26-000010) ↗
Q4 2025Dec 31, 2025-63.0%-68.0 ptsNovartis Form 6-K (0001114448-26-000007) ↗
Q3 2025Sep 30, 2025-38.0%-38.0 ptsNovartis Form 6-K (0001114448-25-000003) ↗
Q2 2025Jun 30, 2025-9.0%-4.0 ptsNovartis Form 6-K (0001370368-25-000012) ↗
Q1 2025Mar 31, 20258.0%+12.0 ptsNovartis Form 6-K (0001370368-25-000010) ↗
Q4 2024Dec 31, 20245.0%+1.0 ptsNovartis Form 6-K (0001370368-25-000007) ↗
Q3 2024Sep 30, 20240.0%-10.0 ptsNovartis Form 6-K (0001370368-24-000022) ↗
Q2 2024Jun 30, 2024-5.0%-16.0 ptsNovartis Form 6-K (0001370368-24-000019) ↗
Q1 2024Mar 31, 2024-4.0%-19.0 ptsNovartis Form 6-K (0001370368-24-000017) ↗
Q4 2023Dec 31, 20234.0%-7.0 ptsNovartis Form 6-K (0001370368-24-000007) ↗
Q3 2023Sep 30, 202310.0%+3.0 ptsNovartis Form 6-K (0001370368-23-000068) ↗
Q2 2023Jun 30, 202311.0%–Novartis Form 6-K (0001370368-23-000059) ↗
Q1 2023Mar 31, 202315.0%–Novartis Form 6-K (0001370368-23-000046) ↗
Q4 2022Dec 31, 202211.0%–Novartis Form 6-K (0001370368-23-000008) ↗

Cite this data

StockData. (2026). Novartis Promacta/Revolade Global Growth in Constant Currencies (%), quarterly Q4 2018–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/brand-promacta-revolade-yoy-cc-pct

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.